Montelukast versus budesonide as a first line preventive therapy in mild persistent asthma in 2 to 18 y.

Abstract

OBJECTIVES To compare the efficacy of oral Montelukast and inhaled Budesonide as a first line preventive therapy in mild persistent asthma in age group 2-18 y. METHODS This prospective randomized controlled clinical study was conducted for 12 wk. Sixty patients of mild persistent asthma aged 2 to 18 y were randomly allocated to either oral Montelukast (n… (More)
DOI: 10.1007/s12098-013-1334-y

4 Figures and Tables

Topics

  • Presentations referencing similar topics